Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Approved for those who can’t tolerate more statins – is this you?
Varying perspectives on a touchy subject, from Kerri Sparling of Six Until Me.
Why I’m so moved by this $45 billion commitment and its focus on health equality.
Award honors innovations to personalize care.
The DreaMed Pump Advisor, Glooko app, Nutshell, and MyStar DoseCoach.
How 14 minutes of exercise can be one small step towards a healthier life.
Bringing added convenience to blood glucose monitoring in smartphone-connected device.
Moving the field closer to finding a cure in humans through an innovative tissue donation program – find out how you can support this work!
How to join focus groups about the human side of closing the loop – all done remotely!
Comment by March 26 to ensure that diabetes devices easily communicate with one another, other devices, and software.
Plus, an interview with Dr. Anne Peters on 23andMe and the future of individualized care.
Gamechanging Xultophy (Tresiba + Victoza) also now submitted to the FDA.
Praluent now approved for two specific patient populations. How this drug has the future potential to make a big impact on people with diabetes.
Enrolling now – how this implanted CGM compares to current CGM offerings.
What can you learn about your health, your ancestry, and more?
Incredible opportunity in San Diego will teach providers how to better motivate and support people with diabetes (Jan 22-23, Feb 26-27).
While Dexcom shook up the diabetes world when it announced a notable partnership with Google , the company also shared several other very exciting future product updates...
How safe and effective is Jardiance in people with type 1 diabetes?
Major organizations make it clear: diabetes education is critical!
Launch before the second half of 2016. What savings program will be offered?

Pages